Article Type
Changed
Tue, 05/21/2019 - 12:19
Display Headline
Exploring the Role of Modified-Release Doxycycline in Rosacea

 

A Journal Scan supplement to Family Practice News®.  This supplement was sponsored by Galderma Laboratories, L.P. 

Topics

 

  • Introduction - Exploring the Role of Modified-Release
  • Doxycycline in Rosacea
  • Comparing Antimicrobial and Anti-Inflammatory Doses of Oral Doxycycline in the Treatment of Rosacea
  • Impact of Antibiotic Resistance on Dermatologic Practice
  • The Effects of Modified-Release Doxycycline on Quality of Life
  • Combining Anti-Inflammatory–Dose Doxycycline With Topical Metronidazole

To view the supplement, click the image above.

Faculty/Faculty Disclosure

Brian Berman, MD, PhD
Voluntary Professor of Dermatology and Cutaneous Surgery
University of Miami, Miller School of Medicine Co-Director
Center for Clinical and Cosmetic Research, Skin & Cancer Associates, LLP, Aventura, FL

 

Dr Berman has received funding for clinical grants from, is an investigator for, and is a consultant to, Galderma Laboratories, L.P.

 

 

Copyright (c) 2012 by Elsevier Inc.

Article PDF
Author and Disclosure Information

 

 

Publications
Sections
Author and Disclosure Information

 

 

Author and Disclosure Information

 

 

Article PDF
Article PDF

 

A Journal Scan supplement to Family Practice News®.  This supplement was sponsored by Galderma Laboratories, L.P. 

Topics

 

  • Introduction - Exploring the Role of Modified-Release
  • Doxycycline in Rosacea
  • Comparing Antimicrobial and Anti-Inflammatory Doses of Oral Doxycycline in the Treatment of Rosacea
  • Impact of Antibiotic Resistance on Dermatologic Practice
  • The Effects of Modified-Release Doxycycline on Quality of Life
  • Combining Anti-Inflammatory–Dose Doxycycline With Topical Metronidazole

To view the supplement, click the image above.

Faculty/Faculty Disclosure

Brian Berman, MD, PhD
Voluntary Professor of Dermatology and Cutaneous Surgery
University of Miami, Miller School of Medicine Co-Director
Center for Clinical and Cosmetic Research, Skin & Cancer Associates, LLP, Aventura, FL

 

Dr Berman has received funding for clinical grants from, is an investigator for, and is a consultant to, Galderma Laboratories, L.P.

 

 

Copyright (c) 2012 by Elsevier Inc.

 

A Journal Scan supplement to Family Practice News®.  This supplement was sponsored by Galderma Laboratories, L.P. 

Topics

 

  • Introduction - Exploring the Role of Modified-Release
  • Doxycycline in Rosacea
  • Comparing Antimicrobial and Anti-Inflammatory Doses of Oral Doxycycline in the Treatment of Rosacea
  • Impact of Antibiotic Resistance on Dermatologic Practice
  • The Effects of Modified-Release Doxycycline on Quality of Life
  • Combining Anti-Inflammatory–Dose Doxycycline With Topical Metronidazole

To view the supplement, click the image above.

Faculty/Faculty Disclosure

Brian Berman, MD, PhD
Voluntary Professor of Dermatology and Cutaneous Surgery
University of Miami, Miller School of Medicine Co-Director
Center for Clinical and Cosmetic Research, Skin & Cancer Associates, LLP, Aventura, FL

 

Dr Berman has received funding for clinical grants from, is an investigator for, and is a consultant to, Galderma Laboratories, L.P.

 

 

Copyright (c) 2012 by Elsevier Inc.

Publications
Publications
Article Type
Display Headline
Exploring the Role of Modified-Release Doxycycline in Rosacea
Display Headline
Exploring the Role of Modified-Release Doxycycline in Rosacea
Sections
Disallow All Ads
Alternative CME
Article PDF Media